pK(a) determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry.
about
Differential bonding interactions of inverse agonists of angiotensin II type 1 receptor in stabilizing the inactive stateHigh-performance liquid chromatographic determination of anti- hypertensive drugs on dried blood spots using a fluorescence detector--method development and validation.Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles.Two selective HPTLC methods for determination of some angiotensin II receptor antagonists in tablets and biological fluids.pH modulation: a mechanism to obtain pH-independent drug release.Simultaneous determination of amlodipine and valsartan.The effect of polysorbate 20 on solubility and stability of candesartan cilexetil in dissolution mediaApplication of capillary zone electrophoresis to the screening of some angiotensin II receptor antagonists.Influence of alkalizers on dissolution properties of telmisartan in solid dispersions prepared by cogrinding.Losartan's affinity to fluid bilayers modulates lipid-cholesterol interactions.Validated spectrofluorimetric determination of two pharmaceutical antihypertensive mixtures containing amlodipine besylate together with either candesartan cilexetil or telmisartan.Optimization of self-microemulsifying drug delivery system for telmisartan using Box-Behnken design and desirability function.Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1.Spectrofluorimetric method for determination of some angiotensin II receptor antagonists.Effect of dietary fibers on losartan uptake and transport in Caco-2 cells.Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets.Quantitative Analysis of Irbesartan in Pharmaceuticals and Human Biological Fluids by Voltammetry
P2860
Q24652998-24E661D7-993E-4D89-821C-7E324E319257Q33817137-5D2E0A9E-645C-4683-9AE0-D20F5FFE10FBQ36162017-9BE796A3-A89D-44EE-958A-97185B1B7404Q36220469-90838C05-0660-4ABB-951C-CA952A781769Q37761375-B624920D-971F-4B2D-81ED-D948C95060F6Q38354322-902FE7B0-F5FA-4B5C-BC64-05F9BBB0ABCBQ41815642-E52A0D16-7B5D-477F-BD13-3663EF123EDEQ43882983-D0D34784-A72C-4BE9-85EB-93582BFDD160Q44052176-580BDA1A-6D02-4C86-93DB-FC7227BB17B9Q44196432-483504F0-A949-4821-9CE5-31261E46A147Q46439109-BC884F65-9AB2-4E34-B1F7-CA3A69F1DC31Q46796981-AED90260-61F5-4BC8-A148-8D417618830FQ50072763-62618A91-0961-47B8-A714-D8563075AEB6Q50196889-754E1345-4813-4C11-9F7E-2E9FCF81769FQ53642893-0F36D522-9F7F-4208-BC08-2E3DD25048C7Q54626013-9D74E9A7-FB91-4E15-9CA3-044381E3F1E1Q58171008-E7EEEBB6-434A-4CE6-B95C-8053611630DF
P2860
pK(a) determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
pK(a) determination of angiote ...... ARA II) by spectrofluorimetry.
@ast
pK(a) determination of angiote ...... ARA II) by spectrofluorimetry.
@en
type
label
pK(a) determination of angiote ...... ARA II) by spectrofluorimetry.
@ast
pK(a) determination of angiote ...... ARA II) by spectrofluorimetry.
@en
prefLabel
pK(a) determination of angiote ...... ARA II) by spectrofluorimetry.
@ast
pK(a) determination of angiote ...... ARA II) by spectrofluorimetry.
@en
P2093
P1476
pK(a) determination of angiote ...... ARA II) by spectrofluorimetry.
@en
P2093
L González
R M Alonso
R M Jiménez
P304
P356
10.1016/S0731-7085(01)00413-7
P577
2001-10-01T00:00:00Z